Element Biosciences

Opening the World of Biology to New Possibilities

San Diego, United States · Founded 2017 · $853.3M raised

Employees
201–500
Founded
2017
Business Model
B2B
Total Funding
$853.3M
Last Round
$175.0M Series EJun 2026
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Element Biosciences is a San Diego-based life science company founded in 2017 by Molly He and other industry veterans. The company develops and commercializes next-generation DNA sequencing systems, including the AVITI and AVITI24 platforms, designed to deliver high-quality sequencing at lower cost than incumbents. Element aims to democratize access to genomic tools for researchers worldwide.

Summary

Element Biosciences is a Biotech company based in San Diego, United States, founded in 2017. It has raised $853.3M in total across 6 rounds, most recently a $175.0M Series E round in Jun 2026. Investors include Samsung Electronics, Wellington Management and Janus Henderson Investors.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries E (Upsized)Jun 2026
$175.0M

Sign up to see all 6 events

Funding: Series A through Series E. Amounts, valuations, and investors where available.

Investors

Acquisitions

Similar Companies

PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Element Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/element-biosciences"><img src="https://indexed.vc/api/badge/company/element-biosciences" alt="Element Biosciences on Indexed.vc" width="260" height="76" /></a>